Pituitary adenylate cyclase-activating polypeptide stimulates insulin and glucagon secretion in humans

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 9, 1997, Pages 3093-3098

  Filipsson, K ^a,c   Tornoe K ^b   Holst, J ^b   Ahren B ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c University Hospital Malmö   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCAGON; GLUCOSE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; INSULIN;

ADULT; ARTICLE; CHROMATOGRAPHY; FEMALE; GLUCAGON BLOOD LEVEL; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN RELEASE; INTRAVENOUS DRUG ADMINISTRATION; PANCREAS; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

BLOOD GLUCOSE; C-PEPTIDE; CHROMATOGRAPHY; FEMALE; GLUCAGON; HUMANS; INSULIN; MIDDLE AGED; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; OSMOLAR CONCENTRATION; PANCREAS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE;

ANIMALIA;

EID: 0030953398     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.9.3093     Document Type: Article

References (28)

1. Miyata A, Arimura A, Dahl RR, et al. 1989 Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun. 164:567-574.
2. Miyata A, Jiang L, Dahl RR, et al. 1990 Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun. 170:643-648.
3. Arimura A, Shioda S. 1995 Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction. Front Neuroendocrinol. 16:53-88.
4. Fridolf T, Sundler F, Ahrén B. 1992 Pituitary adenylate cyclase activating polypeptide (PACAP): occurrence in rodent pancreas and effects on insulin and glucagon secretion in the mouse. Cell Tissue Res. 269:275-279.
5. Yada T, Sakurada M, Ihida K, et al. 1994 Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet β-cells. J Biol Chem. 269:1290-1293.
6. Köves K, Arimura A, Vigh S, Somogyvari-Vigh A, Miller J. 1993 Immunohistochemical localization of PACAP in the ovine digestive system. Peptides. 14:449-455.
7. Hammond PJ, Talbot K, Chapman R, Ghatei MA, Bloom SR. 1993 Vasoactive intestinal peptide, but not pituitary adenylate cyclase-activating peptide, modulates the responsiveness of the gonadotroph to LHRH in man. J Endocrinol. 137:529-532.
8. Chiodera P, Volpi R, Capretti L, Coiro V. 1995 Effects of intravenously infused pituitary adenylate cyclase-activating polypeptide on arginine vasopressin and oxytocin secretion in man. NeuroReport. 6:1490-1492.
9. Neri G, Andreis PG, Prayer-Galetti T, Rossi GP, Malendowicz LK, Nussdorfer GG. 1996 Pituitary adenylate-cydase activating polypeptide enhances aldosteron secretion of human adrenal gland: evidence for an indirect mechanism, probably involving the local release of catecholamines. J Clin Endocrinol Metab. 81:169-173.
10. Kästner A, Bruch L, Will-Shahab L, Modersohn D, Baumann G. 1995 Pituitary adenylate cyclase activating peptides are endothelium-independent dilators of human and porcine coronary arteries. Agents Actions. 45(Suppl):283-289.
11. Warren JB, Cockcroft JR, Larkin SW, et al. 1992 Pituitary adenylate cyclase-activating polypeptide is a potent vasodilator in humans. J Cardiovasc Pharmacol. 20:83-87.
12. af Klinteberg K, Karlsson S, Ahrén B. 1996 Signaling mechanisms underlying the insulinotropic effect of pituitary adenylate cyclase-activating polypeptide in HIT-T15 cells. Endocrinology. 137:2791-2798.
13. Inagaki N, Yoshida H, Mizuta M, et al. 1994 Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells. Proc Natl Acad Sci USA. 91:2679-2683.
14. Yokota C, Kawai K, Ohashi S, Watanabe Y, Suzuki S, Yamashita K. 1993 Stimulatory effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on insulin and glucagon release from the isolated perfused rat pancreas. Acta Endocrinol (Copenh). 129:473-479.
15. Bertrand G, Puech R, Maissonnasse Y, Bockaert J, Loubatières-Mariani MM. 1996 Comparative effects of PACAP and VIP on pancreatic endocrine secretions and vascular resistance in rat. Br J Pharmacol. 117:764-770.
16. Kawai K, Yokota C, Ohasi S, et al. 1994 Pituitary adenylate cyclase-activating polypeptide: effects on pancreatic-adrenal hormone secretion and glucose-lipid metabolism in normal conscious dogs. Metabolism. 43:739-744.
17. Sekiguchi Y, Kasai K, Hasegawa K, Suzuki Y, Shimoda S. 1994 Glycogenolytic activity of pituitary adenylate cyclase activating polypeptide (PACAP) in vivo and in vitro. Life Sci. 55:1219-1228.
18. Wei Y, Mojsov S. 1996 Tissue specific expression of different human receptor types for pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide: implications for their role in human physiology. J Neuroendocrinol. 8:811-818.
19. Holst JJ, Bersani M. 1991 Assays for peptide products of somatostatin gene expression. Methods Neurosci. 5:3-22.
20. Tornøe K, Hannibal J, Giezemann M, Schmidt P, Holst JJ. 1996 PACAP1-27 and 1-38 in the porcine pancreas: occurrence, localization and effects. Ann NY Acad Sci. 805:521-535.
21. Hannibal J, Mikkelsen JD, Clausen H, Hoist JJ, Wulff BS, Fahrenkrug J. 1995 Gene expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat hypothalamus. Regul Pept. 55:133-148.
22. Arimura A, Somogyvári-Vigh A, Miyata A, Mizuno K, Coy DH, Kitada C. 1991 Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes. Endocrinology. 129:2787-2789.
23. Bishop AE, Polak JM, Green IC, Bryant MG, Bloom SR. 1980 The location of VIP in the pancreas of man and rat. Diabetologia. 18:73-78.
24. Rawlings SR, Hezareh M. 1996 Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP/vasoactive intestinal polypeptide receptors: actions on the anterior pituitary gland. Endocr Rev. 17:4-29.
25. Samols E, Bonner-Weir S, Weir GC. 1986 Intra-islet insulin-glucagon-somatostatin relationships. Clin Endocrinol Metab. 15:33-58.
26. Ahrén B, Taborsky Jr GJ, Porte Jr D. 1986 Neuropeptidergic vs. cholinergic and adrenergic regulation of islet hormone secretion. Diabetologia. 29:827-836.
27. Polonsky KS, Rubenstein AH. 1984 C-Peptide as a measure of the secretion and hepatic extraction of insulin. Diabetes. 33:486-494.
28. Savage PJ, Flock EV, Mako ME, Blix PM, Rubenstein AH, Bennett PH. 1979 C-Peptide and insulin secretion in Pima Indians and Caucasians: constant fractional hepatic extraction over a wide range of insulin concentrations and in obesity. J Clin Endocrinol Metab. 48:594-598.